Back to Blog

Patent Assertion Entities (PAEs): Understanding the Landscape

April 26, 2026 Aruna 12 min read
Patent Assertion Entities — intellectual property law and protection

Few topics in intellectual property generate more controversy than patent assertion entities (PAEs) — organizations that acquire patents primarily to license or litigate them rather than to develop or manufacture products. Sometimes called non-practicing entities or patent trolls, PAEs represent a significant force in the U.S. and global patent ecosystems. Whether you are a startup that has received its first demand letter or a Fortune 500 company managing dozens of simultaneous PAE disputes, understanding the PAE landscape is essential to effective IP strategy. PerspireIP helps clients respond to and defend against PAE assertions every day.

What Are Patent Assertion Entities?

Patent assertion entities are companies that hold patents but do not practice them by making or selling products covered by the patents. Instead, their business model revolves around asserting those patents against companies that do make products — extracting licensing fees or litigation settlements. PAEs range from sophisticated, well-capitalized organizations with large legal teams to small shell companies holding a single patent. According to PricewaterhouseCoopers, PAEs accounted for approximately 65 percent of all U.S. patent litigation in recent years, a dramatic increase from less than 25 percent in 2000.

Types of Patent Assertion Entities

Not all PAEs are the same. The landscape includes several distinct types:

  • Aggregators — organizations that acquire large patent portfolios from multiple sources and systematically license them, such as Acacia Research and InterDigital
  • Individual inventor assertion entities — companies formed by inventors to assert their own original patents
  • Failed startup assertion entities — companies that pivoted from product development to patent monetization after their products failed commercially
  • University spin-outs — entities formed to commercialize university-owned patents
  • Litigation funders — investment vehicles that provide financing to patent owners in exchange for a portion of litigation recoveries

How PAEs Operate

PAEs acquire patents from inventors, universities, failed startups, and operating companies, typically paying cents on the dollar of potential licensing value. Once acquired, they conduct infringement analysis to identify products that appear to practice the patented claims. They then send demand letters — sometimes called licensing letters — to dozens or hundreds of potential infringers simultaneously, offering licenses at rates calibrated to be just below the cost of litigation. Many recipients simply pay the demanded license fee to avoid the expense and distraction of litigation, even if they believe the patent is invalid or not infringed. This dynamic is sometimes called the nuisance settlement model.

Defending Against PAE Assertions

Effective defense against patent assertion entities requires a multi-pronged approach. When you receive a demand letter, do not ignore it. Consult IP counsel immediately. The key decision is whether to negotiate a license, challenge the patent’s validity, or litigate the merits. Each path has different cost, risk, and time profiles.

Inter partes review (IPR): The Patent Trial and Appeal Board (PTAB) allows any party to challenge the validity of a patent on novelty or obviousness grounds. IPR proceedings are faster and less expensive than district court litigation and have very high invalidity rates. Many PAE assertions evaporate after an IPR petition is filed because the PAE does not want its patent invalidated and would rather settle. According to the PTAB, approximately 60 percent of patents that reach a final written decision have some or all claims invalidated.

Proactive PAE Defense Strategies

The best defense is preparation before a demand letter arrives:

  • Join a defensive patent aggregator — organizations like Allied Security Trust (AST) and LOT Network provide members with licenses to portfolios that might otherwise be asserted against them
  • Build your own defensive portfolio — owning patents in your technology space gives you cross-licensing leverage and deters assertion
  • Subscribe to patent monitoring services — tools like Docket Navigator and CPi (Competitive Patent Intelligence) can alert you to PAE acquisition activity in your technology area before a demand letter arrives
  • Participate in industry coalitions — the High Tech Inventors Alliance and Open Invention Network provide collective defense resources

The Policy Debate Around PAEs

The role of patent assertion entities in the innovation economy is genuinely contested. Critics argue that PAE litigation taxes productive companies without contributing to innovation, wastes billions in legal fees, and forces small companies to settle invalid claims they cannot afford to fight. Proponents argue that PAEs provide liquidity to inventors who lack the resources to enforce their own patents, that they correct an enforcement asymmetry where large companies infringe small inventors’ patents with impunity, and that patent licensing — even by non-practicing entities — is a legitimate exercise of property rights.

Legislative reforms including the America Invents Act (2011) and various proposed fee-shifting statutes have attempted to address PAE behavior, with mixed results. The debate continues, and the landscape evolves as courts, Congress, and the PTAB issue new rulings and decisions affecting PAE economics.

Conclusion

Patent assertion entities are a permanent feature of the modern IP landscape, not a temporary phenomenon. Companies of all sizes need to understand how PAEs operate, how to respond to assertions, and how to build proactive defenses. PerspireIP helps clients both respond to active PAE assertions and build the portfolio and process infrastructure to minimize their PAE exposure. Knowledge and preparation are the most effective tools in your defense arsenal.

PAE Business Models: How the Economics Work

Understanding PAE business models illuminates how to defend against them. PAEs operate on a portfolio model: they acquire patents cheaply — often for 5 to 15 cents on the dollar of their potential licensing value — and then attempt to extract licensing fees from operating companies at rates that are still below litigation cost but well above acquisition cost. A PAE that buys a patent for $50,000 and sends demand letters to 100 companies seeking $75,000 each in settlement needs only a handful of responses to generate substantial returns.

The economics are further enhanced by contingency fee arrangements with litigation counsel, which eliminate the PAE’s out-of-pocket litigation costs. Litigation funders have added another layer of capital, providing non-recourse financing to PAEs in exchange for a portion of recoveries, enabling larger assertion campaigns with higher-quality patents.

Responding to a PAE Demand Letter

The first 30 days after receiving a PAE demand letter are critical. Common mistakes include: ignoring the letter (it will not go away and may result in a lawsuit before you have prepared a defense); responding hastily without IP counsel review; publicly disparaging the PAE or the patent (this can inflame the dispute and create legal exposure); or immediately agreeing to enter license negotiations without first assessing the strength of the patent. The right initial response is to engage experienced IP litigation counsel immediately, conduct a preliminary assessment of the patent’s validity and claim scope, gather evidence of non-infringement or design-around options, and respond to the PAE professionally and without prejudice while counsel completes the assessment.

Inter Partes Review as a PAE Defense Tool

Inter partes review at the PTAB has become the most effective tool for neutralizing PAE assertions based on weak patents. An IPR petition filed within one year of service of a complaint challenges the patent’s validity on prior art grounds. The PTAB institutes approximately 60 percent of petitions and finds at least some claims unpatentable in approximately 80 percent of instituted proceedings. The mere filing of an IPR petition often changes PAE negotiating behavior — PAEs whose business model depends on nuisance settlements prefer to settle before their patent is placed at risk in PTAB proceedings. For operating companies with strong prior art arguments, filing an IPR is often the most cost-effective path to resolving a PAE demand.

The legal and regulatory environment for PAEs continues to evolve. The America Invents Act created IPR as a major counter to PAE assertion. The Supreme Court’s TC Heartland decision restricting patent venue to the defendant’s state of incorporation has made it harder for PAEs to sue in plaintiff-friendly jurisdictions. The Western District of Texas, which became the busiest patent court in the country after TC Heartland, has faced its own venue scrutiny.

Fee-shifting statutes in exceptional cases — where courts award attorneys’ fees against meritless assertions — have made reckless PAE litigation marginally more risky. However, legislative reform proposals like the PREVAIL Act and the STRONGER Patents Act continue to debate the fundamental rules governing patent validity proceedings and PAE behavior, meaning the landscape will continue to shift.

Practical Tips for Implementation

Translating IP strategy into day-to-day practice requires discipline, clear ownership, and the right support structures. The most successful IP programs share a common set of operational characteristics: IP responsibilities are embedded in standard business processes rather than treated as external compliance requirements; senior leadership reviews IP metrics alongside financial and operational KPIs; the IP team has a direct line to the business strategy function; and outside counsel relationships are managed to align incentives with outcomes rather than rewarding billable hours.

PerspireIP works as an embedded IP strategy partner — providing the expertise and execution capability that most companies cannot build internally at a fraction of the cost of a full in-house IP department. Whether you are a startup building your first patent application or a mid-market company scaling a licensing program, the fundamentals of successful IP strategy are consistent: be deliberate, be systematic, be aligned with business goals, and review regularly.

Common Pitfalls to Avoid

Even companies with sophisticated IP programs fall into predictable traps. Over-investment in non-core technology areas — filing patents on innovations that will never be commercialized or licensed — wastes budget that could better support core portfolio development. Under-investment in international filing leaves key markets unprotected and competitors free to copy. Failing to review and prune aging patents results in mounting maintenance costs for assets that no longer serve the business. Treating IP counsel as a cost center rather than a business partner results in reactive, transactional legal work instead of proactive strategy.

And failing to communicate IP value to the board and investors leads to under-appreciation of IP assets that should be enhancing company valuation. PerspireIP helps clients avoid all of these pitfalls through structured IP program management, regular portfolio reviews, and clear IP value communication to stakeholders at every level of the organization.

The Venue Rule That Reshaped PAE Economics

The single largest change to patent assertion entities as a business was not substantive patent law. It was a venue decision.

In TC Heartland LLC v. Kraft Foods Group Brands LLC, 581 U.S. 258 (2017), the Supreme Court held that for patent cases the residence of a domestic corporation under the venue statute, 28 U.S.C. § 1400(b), means its state of incorporation. A plaintiff can otherwise only sue where the defendant has committed acts of infringement and has a regular and established place of business. The Federal Circuit then narrowed that second route in In re Cray Inc., 871 F.3d 1355 (Fed. Cir. 2017), requiring a physical place in the district that the defendant itself ratifies and uses to conduct business — a remote employee’s home is not enough.

The practical effect was to break up the concentration of assertion filings in a single plaintiff-friendly district, and to redistribute them largely toward Delaware, where most operating companies are incorporated, and toward the Western District of Texas. For a defendant, the first question on receiving a complaint is now a venue question, and a venue motion is often cheaper than any merits defence.

Two other procedural levers changed the arithmetic alongside it:

  • Early eligibility motions. Where the asserted claims are directed to an abstract idea, a motion to dismiss or for judgment on the pleadings under 35 U.S.C. § 101 can resolve a case before expensive discovery. Many assertion campaigns built on software claims drafted before 2014 are vulnerable here, and the cost asymmetry that makes assertion profitable runs the other way once a case can end at the pleadings stage.
  • Fee shifting. Octane Fitness, LLC v. ICON Health & Fitness, Inc., 572 U.S. 545 (2014), loosened the standard for an exceptional-case fee award under 35 U.S.C. § 285 to a totality-of-the-circumstances test decided on a preponderance of the evidence. That gave defendants a credible threat where a campaign is objectively weak or litigated unreasonably, which is exactly the profile of a nuisance-value demand.

None of this makes patent assertion entities go away. It does mean the cheap, high-volume, single-district model is harder to run, and that a defendant who responds procedurally rather than commercially has more to work with than they did a decade ago.

Insurance, Indemnity and Pooled Defense

Defending one assertion well is expensive. Defending the same assertion alongside twenty other defendants, or pushing the cost to a party who already agreed to carry it, is usually the better economics. Three mechanisms are worth having in place before a demand letter arrives.

  1. Supplier indemnity. If the accused functionality came from a component or software vendor, check the contract first and the statute second. Under UCC § 2-312(3) a merchant seller regularly dealing in goods of the kind gives a warranty that the goods are delivered free of any rightful infringement claim, unless disclaimed. Many assertion campaigns target end users of a component precisely because the end users do not think to tender the claim upstream.
  2. IP defence insurance. Specialist policies cover defence costs and sometimes damages for infringement claims. Read the trigger and the exclusions carefully: notice requirements are often strict, prior-knowledge exclusions can defeat a claim where the patentee sent an earlier letter, and defence-cost limits are frequently lower than the real cost of taking a case through claim construction.
  3. Collective defence organisations. These solve different problems and are often confused. Defensive aggregators buy patents off the market so they cannot be asserted. Prior-art and challenge-based groups fund invalidity work and inter partes review against patents asserted against members. License-on-transfer arrangements neutralise a member’s patents automatically if those patents are ever sold to an assertion entity — which protects against future assertion rather than current claims.

Choose by the risk you actually have. If your exposure is a handful of high-value patents already asserted in your sector, invalidity-focused collective work helps most. If your exposure is that a competitor’s portfolio might one day be sold to an assertion entity, a license-on-transfer commitment addresses the risk the others do not.

Whatever you use, document the tender. Sending a timely, well-evidenced indemnity demand or insurance notice costs almost nothing and preserves a right that is easy to waive by delay.

Working With PerspireIP

PerspireIP offers a comprehensive suite of IP strategy and management services designed to meet clients where they are and take them where they want to go. Our services span IP audits and portfolio assessments, patent and trademark prosecution strategy, licensing program design and execution, IP due diligence for M&A transactions, freedom-to-operate analysis, IP enforcement strategy, and ongoing IP portfolio management. We bring deep technical expertise across technology, life sciences, consumer products, and industrial sectors, combined with the business acumen to connect IP decisions to commercial outcomes. Our clients range from pre-revenue startups filing their first provisional applications to Fortune 500 companies managing global licensing programs.

What they share is a commitment to treating IP as the strategic business asset it is — and a recognition that expert IP strategy support pays for itself many times over in stronger competitive position, better deal outcomes, and more effective use of IP budget resources. Contact PerspireIP today to discuss how we can help strengthen your IP strategy and maximize the value of your intellectual property assets.